Clinical Trial Update: Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of irinotecan plus carboplatin for newly diagnosed extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Japan Multinational Trial Organization | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED